Siyuan Chen

No. 7 Weiwu Road
Zhengzhou, 450003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Structural and functional magnetic resonance imaging abnormalities and plasma GLP-1 levels in Parkinson's disease with cognitive impairment.

Structural and functional magnetic resonance imaging abnormalities and plasma GLP-1 levels in Parkinson's disease with cognitive impairment.

Journal: IBRO neuroscience reports

Published: November 06, 2025

The retinal nerve fiber layer mean thickness in patients with early Parkinson's disease reflects striatal dopamine function.

The retinal nerve fiber layer mean thickness in patients with early Parkinson's disease reflects striatal dopamine function.

Journal: Neuroscience

Published: May 25, 2025

Serum sirtuin 3 levels and multimodal abnormalities in brain structure and function in Parkinson's disease patients with depression.

Serum sirtuin 3 levels and multimodal abnormalities in brain structure and function in Parkinson's disease patients with depression.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 11, 2025

Increased plasma GPNMB levels in patients with parkinson's disease and cognitive impairment.

Increased plasma GPNMB levels in patients with parkinson's disease and cognitive impairment.

Journal: Scientific reports

Published: October 10, 2024

Overexpression of solute carrier family 6 member 12 promotes cell injury in Parkinson's disease via MAPK signaling pathway.

Overexpression of solute carrier family 6 member 12 promotes cell injury in Parkinson's disease via MAPK signaling pathway.

Journal: Experimental gerontology

Published: April 03, 2024

Association between kidney function and Parkinson's disease risk: a prospective study from the UK Biobank.

Association between kidney function and Parkinson's disease risk: a prospective study from the UK Biobank.

Journal: BMC public health

Published: February 15, 2024

Lymphocyte antigen 96: A new potential biomarker and immune target in Parkinson's disease.

Lymphocyte antigen 96: A new potential biomarker and immune target in Parkinson's disease.

Journal: Experimental gerontology

Published: January 16, 2024

Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.

Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.

Journal: Neurobiology of disease

Published: October 05, 2023

Relationship of irisin with disease severity and dopamine uptake in Parkinson's disease patients.

Relationship of irisin with disease severity and dopamine uptake in Parkinson's disease patients.

Journal: NeuroImage. Clinical

Published: July 25, 2023

Diagnostic value of plasma SIRT1 levels and whole-brain gray matter volume in Parkinson's disease patients with cognitive impairment.

Diagnostic value of plasma SIRT1 levels and whole-brain gray matter volume in Parkinson's disease patients with cognitive impairment.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: July 18, 2023

Alpha-synuclein in skin as a high-quality biomarker for Parkinson's disease.

Alpha-synuclein in skin as a high-quality biomarker for Parkinson's disease.

Journal: Journal of the neurological sciences

Published: April 28, 2023

Predictors of dopamine dysregulation syndrome in patients with early Parkinson's disease.

Predictors of dopamine dysregulation syndrome in patients with early Parkinson's disease.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: January 18, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026